Where does Perry Nisen work?

Perry Nisen is Executive Advisor, Private Equity at Sofinnova Ventures.

What does Perry Nisen invest in?

Perry Nisen invests in Biotech.

What check size does Perry Nisen write?

Perry Nisen typically writes checks of $100K – $5M.

What boards does Perry Nisen sit on?

Perry Nisen holds tracked board seats at Quanta.

Where did Perry Nisen go to school?

Perry Nisen studied at Albert Einstein College of Medicine (MD, PhD); Stanford University (Bachelor's degree, Medical Microbiology).

Perry Nisen

Investor

Executive Advisor, Private Equity at Sofinnova Ventures

San Diego, California

Writes $100K – $5M checks · typically $1.5M

About

Perry Nisen is a physician scientist with experience in drug discovery and development, focusing on pre-clinical and clinical companies in oncology, neuroscience, and immunology/inflammation. He joined Sofinnova in 2018 and previously served as CEO of the Sanford Burnham Prebys Medical Discovery Institute and held senior roles at GlaxoSmithKline, including SVP of Science and Innovation, interim Chief Medical Officer, and Oncology Therapy Area Head, as well as a cancer research leadership role at Abbott Laboratories. He earned a BS from Stanford University and an MD/PhD from the Albert Einstein College of Medicine.

Contact· self-published, not guessed

p•••@sofinnova.comreveal

Invests in

Biotech

Experience

Quanta TherapeuticsChief Executive Officercurrent2021 — presentSan Francisco and Malvern, PA
Sofinnova InvestmentsExecutive Partner/Advisorcurrent2018 — presentSan Diego County, California, United States
Teva PharmaceuticalsIndependent Director, Chair of Science and Technologycurrent2017 — present
Sanford Burnham Prebys Medical Discovery InstituteChief Executive Officer, Donald Bren Chief Executive Chair2014 — 2017La Jolla, California and Lake Nona, Florida
GlaxoSmithKlineSVP Science and Innovation2012 — 2014
GlaxoSmithKlineInterim Chief Medical Officer2012Greater Philadelphia
GlaxoSmithKlineSenior Vice President and Therapeutic Area Head, Oncology Research and Development2010 — 2012Collegeville, PA
GlaxoSmithKlineSVP Cancer Research2008 — 2010
GlaxoSmithKlineSVP Clinical Pharmacology and Discovery Medicine2004 — 2008
AbbottDivision VP Global Oncology Development2001 — 2004
AbbottDivision VP Cancer Research1997 — 2001
UT Southwestern Medical CenterProfessor1997
UT Southwestern Medical CenterAssociate Professor1992 — 1997
UT Southwestern Medical CenterMember, Genetics and Development Graduate Training Program1989 — 1997
UT Southwestern Medical CenterAssistant Professor1989 — 1992

Skills & more

Oncology47Clinical Development27Drug Development35Biotechnology26Clinical Trials15Lifesciences1Drug Discovery14Immunology7Regulatory Affairs2Biopharmaceuticals6Clinical Research6Life Sciences33

+6 more

MedicineVaccinesInfectious DiseasesR&DResearch and Development (R&D)Pharmaceutical Industry

From Perry's professional profile.

Investments

Board seats

Quanta

Per the firm's website.

Colleagues at Sofinnova Ventures

Alex Chan

Controller, Private Equity at Sofinnova Ventures

Alex Dulnev

IT Manager at Sofinnova Ventures

Amanda Phillips

Executive Assistant at Sofinnova Ventures

Anastasia Voevodin

Analyst, Public Equity at Sofinnova Ventures

Aneal Tenjarla

Partner, Associate Portfolio Manager, Public Equity at Sofinnova Ventures

Calvin Sternick

Analyst, Public Equity at Sofinnova Ventures

Chris Carpenter

Executive Partner, Private Equity at Sofinnova Ventures

David Kabakoff

Executive Partner, Private Equity at Sofinnova Ventures

Frequently asked questions

Who is Perry Nisen?: Perry Nisen is a physician scientist with experience in drug discovery and development, focusing on pre-clinical and clinical companies in oncology, neuroscience, and immunology/inflammation. He joined Sofinnova in 2018 and previously served as CEO of the Sanford Burnham Prebys Medical Discovery Institute and held senior roles at GlaxoSmithKline, including SVP of Science and Innovation, interim Chief Medical Officer, and Oncology Therapy Area Head, as well as a cancer research leadership role at Abbott Laboratories. He earned a BS from Stanford University and an MD/PhD from the Albert Einstein College of Medicine.
Where does Perry Nisen work?: Perry Nisen is Executive Advisor, Private Equity at Sofinnova Ventures.
What does Perry Nisen invest in?: Perry Nisen invests in Biotech.
What check size does Perry Nisen write?: Perry Nisen typically writes checks of $100K – $5M.
What boards does Perry Nisen sit on?: Perry Nisen holds tracked board seats at Quanta.
Where did Perry Nisen go to school?: Perry Nisen studied at Albert Einstein College of Medicine (MD, PhD); Stanford University (Bachelor's degree, Medical Microbiology).